Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why I rate DERM stock a Buy.

Stryker Corporation SYK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks ...

DeepSeek has complicated the dominant narrative that's propped up the market for the last 2 years, challenging lofty ...

Austal's stock surge was driven by significant contracts and positive guidance for FY25. Click here to read why I maintain a ...

When you think of the next big electric vehicle (EV) stock, you might think of those vying to be the next Tesla, such as ...

Gov. Kevin Stitt has issued an executive order that will allow Oklahoma’s colleges and universities to facilitate direct payments to student-athletes for the use of their name, image and ...

Here are five key steps in the online stock trade lifecycle: Let's say you use an online account or a mobile app to buy 25 ...

Image Comics is moving its distribution to Lunar, and comic book shops are likely to see their discounts cut as a result of ...

Netflix Inc.’s stock was flat Friday after Benchmark analysts reiterated their sell rating on the stock even as they raised their price target by 30%, arguing that it’s looking overvalued in a ...

The brokerage also mentioned that after the fantastic run-up in the stock price, it may be time to book profits. Goldman Sachs has a buy call on Trent with target price of Rs 8,000. "Goldman Sachs ...